Cambrex Corp. | |
Stock Exchange | New York Stock Exchange |
EPS |
$2.33 |
Market Cap |
$1.59 B |
Shares Outstanding |
33.66 M |
Public Float |
33.2 M |
Address |
One Meadowlands Plaza East Rutherford New Jersey 07073 United States |
Employees | - |
Website | http://www.cambrex.com |
Updated | 07/08/2019 |
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. |